Moderators | Coefficient (95% CI) | p Value |
Overall recurrence | ||
Study quality | 0.05 (−0.13 to 0.24) | 0.49 |
Publication year | −0.01 (−0.08 to 0.50) | 0.63 |
Number of patients | −0.00 (−0.001 to 0.001) | 0.43 |
Gender (male) | −0.00 (−0.003 to 0.001) | 0.16 |
+PLC <5% | 0.42 (−0.42 to 1.27) | 0.25 |
+PLC 5–10% | −0.47 (−1.12 to 0.18) | 0.12 |
+PLC 10–20% | −0.34 (−1.28 to 0.60) | 0.40 |
+PLC >20% | 0.54 (−0.25 to 1.32) | 0.14 |
Pleural recurrence | ||
Study quality | 0.11 (0.03 to 0.20) | 0.02 |
Publication year | −0.01 (−0.07 to 0.04) | 0.55 |
Number of patients | 0.00 (−0.001 to 0.001) | 0.84 |
Gender (male) | −0.19 (−1.43 to 1.05) | 0.71 |
+PLC <5% | 0.35 (−0.36 to 1.07) | 0.26 |
+PLC 5–10% | −0.51 (−0.84 to 0.17) | 0.01 |
+PLC 10–20% | 0.21 (−0.35 to 0.77) | 0.38 |
+PLC >20% | 0.03 (−0.87 to 0.92) | 0.95 |
Distant recurrence | ||
Study quality | 0.05 (−0.15 to 0.24) | 0.56 |
Publication year | −0.01 (−0.07 to 0.05) | 0.67 |
Number of patients | 0.00 (−0.001 to 0.001) | 0.44 |
Gender (male) | 0.75 (−0.46 to 1.95) | 0.17 |
+PLC <5% | 0.22 (−0.57 to 1.00) | 0.51 |
+PLC 5–10% | −0.39 (−1.11 to 0.33) | 0.22 |
+PLC 10–20% | −0.45 (−1.40 to 0.49) | 0.27 |
+PLC >20% | 0.64 (−0.06 to 1.34) | 0.07 |
PLC, pleural lavage cytology.